ArticleFrontiers in immunology2019

Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment.

Jürgen Haas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.